prikaz prve stranice dokumenta Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur
  Preuzmi
PDF 1.46 MB
Stručni rad - Sažetak stručnog rada s konferencije (pozvano predavanje)
Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur
U: European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome. Springer, 2010. str. 11. urn:nbn:hr:264:493295
Mikulić, Danko; Jadrijević, Stipislav; Škopljanac, Andrija; Kocman, Ivica; Suknaić, Slaven; Mrzljak, Anna; Kocman, Branislav

Institucijski repozitorij: Repozitorij Kliničke bolnice Merkur

Citirajte ovaj rad

Mikulić, D., Jadrijević, S., Škopljanac, A., Kocman, I., Suknaić, S., Mrzljak, A. i Kocman, B. (2010). Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur. European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome (str. 11). Springer. Preuzeto s https://urn.nsk.hr/urn:nbn:hr:264:493295

Mikulić, Danko, et al. "Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur." European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome, Springer, 2010, str. 11. https://urn.nsk.hr/urn:nbn:hr:264:493295

Mikulić, Danko, Stipislav Jadrijević, Andrija Škopljanac, Ivica Kocman, Slaven Suknaić, Anna Mrzljak i Branislav Kocman. "Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur." U European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome, 11. Springer, 2010. Citirano 27.12.2024.. https://urn.nsk.hr/urn:nbn:hr:264:493295

Mikulić, D., et al. (2010) 'Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur', European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome, Springer, str. 11. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:264:493295 (Datum pristupa: 27.12.2024.)

Mikulić D, Jadrijević S, Škopljanac A, Kocman I, Suknaić S, Mrzljak A, i sur.. Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur. European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome. Springer; 2010. Str. 11-11. [pristupljeno 27.12.2024.] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:264:493295

D. Mikulić, et al., "Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur", European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome Springer, 2010. [Online] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:264:493295 [Citirano: 27.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:264:493295
Podaci o radu
Naslov (engleski)Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur
AutorDanko Mikulić
AutorStipislav Jadrijević
AutorAndrija Škopljanac
AutorIvica Kocman
AutorSlaven Suknaić
AutorAnna Mrzljak
AutorBranislav Kocman
Autorova ustanova(Klinička bolnica Merkur)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Kirurgija
Sažetak (engleski)
Orthotopic liver transplantation (OLT) is the most efficient option for the treatment of hepatocellular carcinoma(HCC) in terms of survival and recurrence rate provided that restrictive selection criteria are applied. However, tumor recurrence occurs in 3.5–30% of recipients and it has a negative impact on prognosis. In this retrospective study we analyzed survival and tumor recurrence rate in a cohort of patients with HCC treated with OLT in a single center. Between 2005 and 2009 30 patients with HCC were transplanted. Mean age was 58þ5.28 years. Twenty-two patients were male and 8 were female. Etiology was viral in 12 patients (30%), alcoholic in 14 (46.6%) and miscellaneous in 4 patients (13.3%). After a median follow-up of 30.8 months, 25 recipients(83.3%) were alive. Eight patients (26.6%) had disease recurrence. Twenty-one patients (70%) were transplanted within and 9 patients (30%) were outside Milan criteria. A higher recurrence rate was noted in patients surpassing the Milan criteria. OLT is an effective mode of treatment for patients with HCC providing low recurrence rates and survival comparable to liver transplantation for benign disease if restrictive selection criteria are applied.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeStručni rad - Sažetak stručnog rada s konferencije (pozvano predavanje)
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov zbornikaEuropean Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome
IzdanjeEuropean Surgery
Brojčani podacivol. 42, br. suppl. 235, str. 11
p-ISSN1682-8631
e-ISSN1682-4016
URN:NBNurn:nbn:hr:264:493295
Datum objave publikacije2010
ProjektŠifra: 108-1081873-1893
Naziv (hrvatski): Prognostički faktori, dijagnostika i terapija hemoblastoza (Jakšić, Branimir, MZOS )
Voditelj: Branimir jakšić
Pravna nadležnost: Hrvatska
Financijer: MZOS
Linija financiranja: zprojekti
SkupNaziv: 3rd Central European Congress of Surgery, Norman Barret Symposium
Lokacija: Dubrovnik, Hrvatska
Datum početka: 2010-04-28
Datum završetka: 2010-05-01
Vrsta izlaganja: Predavanje
URL dokumentahttps://link.springer.com/article/10.1007/s10353-010-0530-5
Vrsta resursaTekst
IzdavačSpringer
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2023-02-28 11:14:18